INVESTOR PRESENTATION May 8, 2014

22 Forward Looking Statements This presentation contains forward-looking statements, which involve numerous risks and uncertainties. Included are statements relating to opening of new clinics, availability of personnel and reimbursement environment. The forward-looking statements are based on the Company’s current views and assumptions and the Company’s actual results could differ materially from those anticipated as a result of certain risks, uncertainties, and factors, which include, but are not limited to: general economic, business, and regulatory conditions; competition; reimbursement conditions; federal and state regulation; acquisitions; clinic closures, availability, terms, and use of capital; availability and cost of skilled physical and occupational therapists; and weather. 2

Investment Highlights 485 outpatient physical and occupational therapy clinics across 43 states 3 rd largest owner/operator of clinics Only publicly-traded, pure play provider 485 outpatient physical and occupational therapy clinics across 43 states 3 rd largest owner/operator of clinics Only publicly-traded, pure play provider Proven Business Model Solid Financial Position Diversified payor mix, only 22% of revs from Medicare Strong cash flow and balance sheet Diversified payor mix, only 22% of revs from Medicare Strong cash flow and balance sheet Driven by organic growth and acquisitions Approximately 60% of clinics are de novo start-ups Partner with experienced physical therapists Driven by organic growth and acquisitions Approximately 60% of clinics are de novo start-ups Partner with experienced physical therapists 3 Attractive Market Dynamics US rehab market > $15B in annual revenue Highly fragmented; No company with >6% market share Favorable demographics – aging and active population US rehab market > $15B in annual revenue Highly fragmented; No company with >6% market share Favorable demographics – aging and active population Established Company

National Footprint 4

Growth Strategy Drive organic growth through de novo PT/OT clinic openings, utilize true partnership model Maximize profits of existing facilities by growing patient volume; realize efficiencies through higher clinical productivity Augment organic growth through strategic acquisitions 5

Large and Growing Market Opportunity $15B+ U.S. rehab market with 3-4% projected annual growth Favorable demographics – physically active, aging and obese population segments Healthcare delivery shifting towards lower cost, high quality outpatient providers “Demand for physical therapy is projected to be one of the fastest growing sectors in the U.S. economy through 2016.” - Wall Street Journal, July 14, 2009 “Jobs in healthcare support…are projected to experience even faster growth. The increased demand in this area stems largely from an aging population…occupations that will likely grow in importance are physical therapists, physical therapist assistants…” − Report from Executive Office of the President’s Council of Economic Advisors, July

Competitive Landscape Highly fragmented U.S. outpatient rehab market with ~16,000 clinics No company with >6% market share USPh ranks third nationally –Select Medical1,017 Clinics –Physiotherapy Associates590 Clinics –USPh 485 Clinics 7

Focused Business Model Specialize in trauma, sports, work-related and pre and post surgical cases Partner with experienced physical therapists –Drive volume via referrals –Augment sales with marketing reps Historical focus on organic growth via lower cost de novo (start-up) clinics Strategic acquisitions structured like de novos as partnerships with significant ownership retained by founders 8

USPH Partnership Advantages Accounting HR Real Estate Construction Purchasing Marketing Compliance Legal IT Less Administrative Burden No Personal Financial Risk Unlimited Earnings Potential Full Benefit Package Ongoing Guidance within Semi-Autonomous Work Environment More Resources 9

10 Video Placeholder

New Clinics / Brands

Acquisition Strategy Completed 17 clinic group acquisitions since 2005 Range in size from 3 to 52 clinics Acquisition criteria: Owner therapists continue to operate clinics and retain significant equity interest Immediately accretive to earnings Further de novo growth opportunities 12

Executive Management Chris Reading – Chief Executive Officer –Joined USPh as COO in November 2003 –Promoted to CEO and Board in November 2004 –Previously Senior Vice President of Operations with HealthSouth, managed over 200 facilities including OP, ASC, DX Imaging and rehab hospital operations. –BS & Physical Therapist Larry McAfee – Chief Financial Officer –Joined USPh as CFO in September 2003 –Promoted to EVP and Board in November 2004 –Previously served as CFO and President of both public and private companies –BBA & MBA Glenn McDowell – Chief Operating Officer –Joined USPh as Vice President - West Region in October 2003 –Promoted to COO in January 2005 –Previously Vice President of Operations with HealthSouth, managed 165 facilities including ASC, DX Imaging, OP and occupational medicine facilities. –BS & Masters Physical Therapy 13

Diversified Payor Mix 14

Strong Cash Flow and Balance Sheet Both de novo clinics and acquisitions financed primarily through free cash flow USPH adjusted trailing twelve months March 2014 EBITDA (1) of $39.6 million (1) Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization, gain on purchase price settlement and equity compensation expense. 15

Dividend In 2011 initiated quarterly dividend Increased dividend in 2012 and 2013 Paid special dividend in December 2012 Increased dividend in March 2014 by 20% Dividends do not impact ability to continue to grow internally through de novo clinic development and externally through acquisitions Dividend seen as additional way to increase returns to shareholders as Company is under leveraged and has excellent net free cash flow 16

Average Annual Rate of Return to Shareholders – 20.1% Per Year 17 * Current Management Team joined Company in Fall of Total Cumulative Return through December 31, 2013 including dividends is $ Total Cumulative Return Percentage is 200.9%. Average Annual Return 20.1%. Market Cap Increase during time period from $154.7 million to $426.8 million..

Revenue Gross Margin Operating Income Net Income EPS Adjusted EBITDA First Quarter Results* 18 $ 69.8 M $ 16.6 M $ 9.5 M $ 4.2 M $.35 $ 9.5 M Q $ 62.8 M $ 14.8 M $ 8.4 M $ 3.9 M $.32 $ 8.5 M 11.2% Q % 12.8% 9.8% 9.1% 12.7% * From continuing operations

Summary 19 Only publicly-traded, pure play operator of rehab clinics Proven business model, driven by organic growth and acquisitions Significant scale with national footprint Large and growing market/favorable demographics Strong cash flow and balance sheet

Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization and equity compensation expense. 20 From Continuing Operations Trailing Twelve Months Ended March 31 (amounts in 000’s) Net revenues$ 271,069$ 250,636 Net Income attributable to U.S. Physical Therapy 17,869 17,627 Depreciation & amortization 5,560 5,233 Interest, net (income) / expense Non-controlling interests 8,648 8,089 Equity/stock option expense 2,839 2,194 Provision for income taxes 12,682 10,836 Adjusted EBITDA before noncontrolling interests 48,248 44,503 Noncontrolling interests (8,648) (8,089) Adjusted EBITDA$ 39,600$ 36,414

Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization and equity compensation expense. 21 From Continued Operations Three Months Ended March 31, 2014 (amounts in 000’s) Net revenues$ 69,767$ 62,756 Net Income attributable to U.S. Physical Therapy 4,228 3,851 Depreciation & amortization 1,387 1,352 Interest, net (income) / expense Non-controlling interests 2,095 1,958 Equity/grant expense Provision for income taxes 2,939 2,493 Adjusted EBITDA before non-controlling interests 11,636 10,426 Noncontrolling interests (2,095) (1,958) Adjusted EBITDA$ 9,541$ 8, %

NYSE: USPH